Janakiraman Subramanian, MD, MPH

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Astra Zeneca
    Topic:
    Speaker/Advisor
    Date added:
    11/01/2023
    Date updated:
    06/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Daiichi
    Topic:
    Advisor
    Date added:
    11/01/2023
    Date updated:
    06/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Jazz Pharma
    Topic:
    Speaker
    Date added:
    11/01/2023
    Date updated:
    06/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen
    Topic:
    Speaker
    Date added:
    11/01/2023
    Date updated:
    06/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    G1 therapeutics
    Topic:
    speaker
    Date added:
    11/01/2023
    Date updated:
    06/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Oncohost
    Topic:
    speaker
    Date added:
    11/01/2023
    Date updated:
    06/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Topic:
    advisor
    Date added:
    11/01/2023
    Date updated:
    06/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    GLG
    Topic:
    advisor
    Date added:
    11/01/2023
    Date updated:
    06/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Guidepoint
    Topic:
    advisor
    Date added:
    11/01/2023
    Date updated:
    06/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Cancer Expert Now
    Topic:
    advisor
    Date added:
    11/01/2023
    Date updated:
    06/04/2024

Pages

Return to Sept. 27-28, 2024 - Symposium for Evolving Therapies and Drug Development in Oncology